| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | SLC6A1 GABRB3 SLC25A3 ATP1B4 SIDT2 ATP8B4 PKD2L2 SLC16A4 TRPM7 SLC6A16 ABCA12 NIPAL2 XKR8 ATG9A ASIC5 NMUR2 SLC7A6 SLC13A2 ATP10D GABRA3 | 1.54e-11 | 1289 | 51 | 20 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A1 GABRB3 SLC25A3 ATP1B4 SIDT2 PKD2L2 SLC16A4 TRPM7 SLC6A16 ABCA12 NIPAL2 ASIC5 NMUR2 SLC7A6 SLC13A2 GABRA3 | 2.01e-08 | 1180 | 51 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.91e-07 | 51 | 51 | 5 | GO:0140303 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC6A1 GABRB3 SLC25A3 ATP1B4 PKD2L2 TRPM7 NIPAL2 ASIC5 NMUR2 SLC13A2 GABRA3 | 2.61e-06 | 758 | 51 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A1 GABRB3 SLC25A3 PKD2L2 TRPM7 NIPAL2 ASIC5 NMUR2 SLC13A2 GABRA3 | 2.69e-05 | 793 | 51 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | symporter activity | 3.98e-05 | 150 | 51 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 4.92e-05 | 28 | 51 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 7.42e-05 | 171 | 51 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.04e-04 | 296 | 51 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.41e-04 | 196 | 51 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.75e-04 | 627 | 51 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.98e-04 | 477 | 51 | 7 | GO:0022804 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 2.83e-04 | 50 | 51 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.91e-04 | 125 | 51 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 3.58e-04 | 884 | 51 | 9 | GO:0004930 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water | 4.90e-04 | 13 | 51 | 2 | GO:0016717 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRB3 TAS2R10 ADGRL1 OR6K3 TAS2R41 CCR8 NMUR2 GPR160 OR4L1 HRH3 GABRA3 | 5.09e-04 | 1353 | 51 | 11 | GO:0004888 |
| GeneOntologyMolecularFunction | AP-2 adaptor complex binding | 5.71e-04 | 14 | 51 | 2 | GO:0035612 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 5.96e-04 | 151 | 51 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 9.31e-04 | 75 | 51 | 3 | GO:0098960 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 9.53e-04 | 18 | 51 | 2 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 1.06e-03 | 19 | 51 | 2 | GO:0004890 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.07e-03 | 459 | 51 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.15e-03 | 465 | 51 | 6 | GO:0046873 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.38e-03 | 86 | 51 | 3 | GO:0005254 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.41e-03 | 664 | 51 | 7 | GO:0008324 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.43e-03 | 22 | 51 | 2 | GO:0016917 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.48e-03 | 193 | 51 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 1.56e-03 | 23 | 51 | 2 | GO:0017128 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.60e-03 | 197 | 51 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.92e-03 | 207 | 51 | 4 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.95e-03 | 208 | 51 | 4 | GO:0005342 | |
| GeneOntologyMolecularFunction | channel activity | 2.12e-03 | 525 | 51 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.13e-03 | 100 | 51 | 3 | GO:0030594 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 2.14e-03 | 526 | 51 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 2.16e-03 | 27 | 51 | 2 | GO:0033038 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 2.32e-03 | 103 | 51 | 3 | GO:0005253 | |
| GeneOntologyMolecularFunction | taste receptor activity | 3.21e-03 | 33 | 51 | 2 | GO:0008527 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 3.49e-03 | 119 | 51 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 3.61e-03 | 35 | 51 | 2 | GO:0005343 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 4.02e-03 | 37 | 51 | 2 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 4.24e-03 | 38 | 51 | 2 | GO:0070001 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 6.61e-03 | 293 | 51 | 4 | GO:0008514 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 9.33e-03 | 57 | 51 | 2 | GO:1904315 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 9.51e-03 | 171 | 51 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.03e-02 | 60 | 51 | 2 | GO:0099529 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.04e-02 | 334 | 51 | 4 | GO:0022836 | |
| GeneOntologyMolecularFunction | NADP binding | 1.10e-02 | 62 | 51 | 2 | GO:0050661 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.20e-02 | 65 | 51 | 2 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.20e-02 | 65 | 51 | 2 | GO:0022824 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 1.54e-02 | 74 | 51 | 2 | GO:0005548 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.66e-02 | 77 | 51 | 2 | GO:0005230 | |
| GeneOntologyBiologicalProcess | lipid translocation | 3.72e-07 | 60 | 51 | 5 | GO:0034204 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 5.58e-07 | 65 | 51 | 5 | GO:0097035 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 2.88e-06 | 162 | 51 | 6 | GO:0015748 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC6A1 GABRB3 SLC25A3 ATP1B4 PKD2L2 TRPM7 SLC6A16 NIPAL2 ASIC5 NMUR2 SLC13A2 ATP10D HRH3 GABRA3 | 3.97e-06 | 1374 | 51 | 14 | GO:0006811 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC6A1 GABRB3 SLC25A3 ATP1B4 PKD2L2 TRPM7 SLC6A16 NIPAL2 ASIC5 NMUR2 SLC13A2 GABRA3 | 5.16e-06 | 1017 | 51 | 12 | GO:0098660 |
| GeneOntologyBiologicalProcess | phospholipid transport | 6.34e-06 | 106 | 51 | 5 | GO:0015914 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 1.03e-05 | 55 | 51 | 4 | GO:0045332 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC6A1 GABRB3 SLC25A3 PKD2L2 TRPM7 SLC6A16 NIPAL2 ASIC5 NMUR2 SLC13A2 ATP10D GABRA3 | 1.31e-05 | 1115 | 51 | 12 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.98e-05 | 134 | 51 | 5 | GO:0098661 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 8.12e-05 | 180 | 51 | 5 | GO:0015698 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 1.69e-04 | 112 | 51 | 4 | GO:1902476 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of bitter taste | 1.76e-04 | 44 | 51 | 3 | GO:0001580 | |
| GeneOntologyBiologicalProcess | sensory perception of bitter taste | 2.28e-04 | 48 | 51 | 3 | GO:0050913 | |
| GeneOntologyBiologicalProcess | lipid transport | 2.33e-04 | 506 | 51 | 7 | GO:0006869 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of taste | 2.57e-04 | 50 | 51 | 3 | GO:0050912 | |
| GeneOntologyBiologicalProcess | organic anion transport | 2.60e-04 | 515 | 51 | 7 | GO:0015711 | |
| GeneOntologyBiologicalProcess | chloride transport | 2.82e-04 | 128 | 51 | 4 | GO:0006821 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC6A1 SLC25A3 ATP1B4 PKD2L2 TRPM7 SLC6A16 NIPAL2 ASIC5 SLC13A2 | 3.84e-04 | 922 | 51 | 9 | GO:0098662 |
| GeneOntologyBiologicalProcess | lipid localization | 4.54e-04 | 565 | 51 | 7 | GO:0010876 | |
| GeneOntologyBiologicalProcess | regulation of gamma-aminobutyric acid secretion | 4.59e-04 | 13 | 51 | 2 | GO:0014052 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC6A1 SLC25A3 ATP1B4 PKD2L2 TRPM7 SLC6A16 NIPAL2 ASIC5 SLC13A2 ATP10D | 4.61e-04 | 1157 | 51 | 10 | GO:0006812 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 5.03e-04 | 410 | 51 | 6 | GO:0046942 | |
| GeneOntologyBiologicalProcess | organic acid transport | 5.16e-04 | 412 | 51 | 6 | GO:0015849 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 5.55e-04 | 153 | 51 | 4 | GO:0098656 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 5.78e-04 | 275 | 51 | 5 | GO:0006814 | |
| GeneOntologyBiologicalProcess | sensory perception of taste | 6.94e-04 | 70 | 51 | 3 | GO:0050909 | |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 8.16e-04 | 74 | 51 | 3 | GO:0051932 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 1.08e-03 | 183 | 51 | 4 | GO:0006820 | |
| GeneOntologyBiologicalProcess | memory | 1.08e-03 | 183 | 51 | 4 | GO:0007613 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid secretion | 1.11e-03 | 20 | 51 | 2 | GO:0014051 | |
| MousePheno | abnormal GABA-mediated receptor currents | 1.59e-05 | 18 | 39 | 3 | MP:0004008 | |
| Domain | Hydrolase_3 | 2.99e-04 | 10 | 49 | 2 | PF08282 | |
| Domain | P_typ_ATPase_c | 6.01e-04 | 14 | 49 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 6.01e-04 | 14 | 49 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 6.01e-04 | 14 | 49 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 6.01e-04 | 14 | 49 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 6.01e-04 | 14 | 49 | 2 | PF16209 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 1.00e-03 | 18 | 49 | 2 | PS00754 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 1.12e-03 | 19 | 49 | 2 | PS50267 | |
| Domain | PA | 1.12e-03 | 19 | 49 | 2 | PF02225 | |
| Domain | PA_domain | 1.12e-03 | 19 | 49 | 2 | IPR003137 | |
| Domain | SNF | 1.12e-03 | 19 | 49 | 2 | PF00209 | |
| Domain | Na/ntran_symport | 1.12e-03 | 19 | 49 | 2 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 1.12e-03 | 19 | 49 | 2 | PS00610 | |
| Domain | GABAA/Glycine_rcpt | 1.65e-03 | 23 | 49 | 2 | IPR006028 | |
| Domain | TAS2R | 2.11e-03 | 26 | 49 | 2 | PF05296 | |
| Domain | T2R | 2.11e-03 | 26 | 49 | 2 | IPR007960 | |
| Domain | - | 3.18e-03 | 32 | 49 | 2 | 2.70.150.10 | |
| Domain | - | 3.18e-03 | 32 | 49 | 2 | 3.40.1110.10 | |
| Domain | ATPase_P-typ_cyto_domN | 3.80e-03 | 35 | 49 | 2 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 4.01e-03 | 36 | 49 | 2 | IPR018303 | |
| Domain | P_typ_ATPase | 4.01e-03 | 36 | 49 | 2 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 4.01e-03 | 36 | 49 | 2 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 4.24e-03 | 37 | 49 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 4.24e-03 | 37 | 49 | 2 | PF00122 | |
| Domain | Neurotransmitter_ion_chnl_CS | 6.21e-03 | 45 | 49 | 2 | IPR018000 | |
| Domain | Neur_chan_memb | 6.48e-03 | 46 | 49 | 2 | PF02932 | |
| Domain | Neur_chan_LBD | 6.76e-03 | 47 | 49 | 2 | PF02931 | |
| Domain | Neur_channel | 6.76e-03 | 47 | 49 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 6.76e-03 | 47 | 49 | 2 | IPR006202 | |
| Domain | NEUROTR_ION_CHANNEL | 6.76e-03 | 47 | 49 | 2 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 6.76e-03 | 47 | 49 | 2 | IPR006029 | |
| Domain | - | 6.76e-03 | 47 | 49 | 2 | 2.70.170.10 | |
| Domain | GPCR_Rhodpsn_7TM | 7.85e-03 | 670 | 49 | 6 | IPR017452 | |
| Domain | zf-RING_2 | 8.22e-03 | 52 | 49 | 2 | PF13639 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 8.71e-03 | 685 | 49 | 6 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 9.07e-03 | 691 | 49 | 6 | PS50262 | |
| Domain | GPCR_Rhodpsn | 9.13e-03 | 692 | 49 | 6 | IPR000276 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A1 ATP8B4 TRPM7 ABCA12 PIP NIPAL2 ASIC5 SLC7A6 SLC13A2 ATP10D | 8.94e-06 | 681 | 38 | 10 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A1 ATP8B4 TRPM7 ABCA12 PIP NIPAL2 ASIC5 SLC7A6 SLC13A2 ATP10D | 1.76e-05 | 736 | 38 | 10 | M27287 |
| Pathway | WP_GPCRS_NONODORANT | 7.09e-05 | 266 | 38 | 6 | MM15843 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 7.71e-05 | 31 | 38 | 3 | M39369 | |
| Pubmed | 2.53e-06 | 18 | 52 | 3 | 18985723 | ||
| Pubmed | Anterograde trafficking signals in GABAA subunits are required for functional expression. | 6.57e-06 | 3 | 52 | 2 | 31610743 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 18085588 | ||
| Pubmed | GABA(A) receptor downregulation in brains of subjects with autism. | 1.31e-05 | 4 | 52 | 2 | 18821008 | |
| Pubmed | The E3 ubiquitin ligase GREUL1 anteriorizes ectoderm during Xenopus development. | 3.28e-05 | 6 | 52 | 2 | 12435366 | |
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 7560270 | ||
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 4.58e-05 | 7 | 52 | 2 | 20843900 | |
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 16101898 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 8175718 | ||
| Pubmed | Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation. | 6.10e-05 | 8 | 52 | 2 | 18185516 | |
| Pubmed | GABA influences the development of the ventromedial nucleus of the hypothalamus. | 6.10e-05 | 8 | 52 | 2 | 11745664 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 11528422 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 23202519 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 11854532 | ||
| Pubmed | Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex. | 1.20e-04 | 11 | 52 | 2 | 38894703 | |
| Pubmed | 1.97e-04 | 14 | 52 | 2 | 22768092 | ||
| Pubmed | 3.30e-04 | 18 | 52 | 2 | 19078961 | ||
| Pubmed | 4.52e-04 | 21 | 52 | 2 | 25708312 | ||
| Pubmed | 4.52e-04 | 21 | 52 | 2 | 10761934 | ||
| Pubmed | 4.52e-04 | 21 | 52 | 2 | 37045597 | ||
| Pubmed | Evolutionary relationships of the Tas2r receptor gene families in mouse and human. | 4.97e-04 | 22 | 52 | 2 | 12734386 | |
| Pubmed | The molecular receptive ranges of human TAS2R bitter taste receptors. | 5.44e-04 | 23 | 52 | 2 | 20022913 | |
| Pubmed | 5.93e-04 | 24 | 52 | 2 | 9606417 | ||
| Pubmed | KIF14 negatively regulates Rap1a-Radil signaling during breast cancer progression. | 5.93e-04 | 24 | 52 | 2 | 23209302 | |
| Pubmed | 6.43e-04 | 25 | 52 | 2 | 12139982 | ||
| Pubmed | Molecular mechanisms of bitter and sweet taste transduction. | 6.96e-04 | 26 | 52 | 2 | 11696554 | |
| Pubmed | 7.51e-04 | 27 | 52 | 2 | 12581520 | ||
| Pubmed | 7.51e-04 | 27 | 52 | 2 | 16460286 | ||
| Pubmed | Lineage-specific loss of function of bitter taste receptor genes in humans and nonhuman primates. | 8.08e-04 | 28 | 52 | 2 | 15744053 | |
| Pubmed | Adaptive diversification of bitter taste receptor genes in Mammalian evolution. | 9.29e-04 | 30 | 52 | 2 | 12679530 | |
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | 9.43e-04 | 128 | 52 | 3 | 19058789 | |
| Pubmed | 9.92e-04 | 31 | 52 | 2 | 37816598 | ||
| Pubmed | 1.12e-03 | 33 | 52 | 2 | 19834762 | ||
| Pubmed | 1.19e-03 | 34 | 52 | 2 | 15496549 | ||
| Pubmed | 1.49e-03 | 150 | 52 | 3 | 32423001 | ||
| Interaction | POMT2 interactions | 1.36e-05 | 60 | 49 | 4 | int:POMT2 | |
| Interaction | FZD8 interactions | 2.31e-05 | 23 | 49 | 3 | int:FZD8 | |
| Interaction | GABRD interactions | 2.99e-05 | 25 | 49 | 3 | int:GABRD | |
| Interaction | GPR21 interactions | 4.47e-05 | 81 | 49 | 4 | int:GPR21 | |
| Interaction | ROGDI interactions | 7.00e-05 | 33 | 49 | 3 | int:ROGDI | |
| Interaction | EDIL3 interactions | 8.37e-05 | 35 | 49 | 3 | int:EDIL3 | |
| Interaction | TPRA1 interactions | 9.11e-05 | 36 | 49 | 3 | int:TPRA1 | |
| Interaction | ADGRL3 interactions | 1.07e-04 | 38 | 49 | 3 | int:ADGRL3 | |
| Interaction | CHRNB2 interactions | 1.14e-04 | 103 | 49 | 4 | int:CHRNB2 | |
| Interaction | PTPN1 interactions | 1.20e-04 | 625 | 49 | 8 | int:PTPN1 | |
| Interaction | RHOJ interactions | 1.31e-04 | 633 | 49 | 8 | int:RHOJ | |
| Interaction | SHANK1 interactions | 1.35e-04 | 41 | 49 | 3 | int:SHANK1 | |
| Interaction | HTR3A interactions | 1.37e-04 | 108 | 49 | 4 | int:HTR3A | |
| Interaction | NTN3 interactions | 1.61e-04 | 8 | 49 | 2 | int:NTN3 | |
| Interaction | DBX2 interactions | 1.61e-04 | 8 | 49 | 2 | int:DBX2 | |
| Interaction | SMTN interactions | 1.67e-04 | 44 | 49 | 3 | int:SMTN | |
| Interaction | AP3B2 interactions | 1.78e-04 | 45 | 49 | 3 | int:AP3B2 | |
| Interaction | RHOF interactions | 1.99e-04 | 673 | 49 | 8 | int:RHOF | |
| Interaction | ASIC5 interactions | 2.06e-04 | 9 | 49 | 2 | int:ASIC5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 4.33e-04 | 129 | 52 | 3 | chr2q35 | |
| GeneFamily | Solute carriers | 2.14e-04 | 395 | 40 | 6 | 752 | |
| GeneFamily | ATPase phospholipid transporting | 4.92e-04 | 15 | 40 | 2 | 1210 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 7.97e-04 | 19 | 40 | 2 | 563 | |
| GeneFamily | Transient receptor potential cation channels | 1.74e-03 | 28 | 40 | 2 | 249 | |
| GeneFamily | Taste 2 receptors | 3.36e-03 | 39 | 40 | 2 | 1162 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.24e-06 | 185 | 51 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.30e-06 | 186 | 51 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.46e-05 | 161 | 51 | 4 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 178 | 51 | 4 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | HSPCs-Neutro_prog.|World / Lineage and Cell class | 5.58e-05 | 182 | 51 | 4 | f2512354b90f55bf4172c28084bf52cf79e41d8a | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.95e-05 | 185 | 51 | 4 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | (5)_Glands_duct|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 6.07e-05 | 186 | 51 | 4 | ad8d5010e5095508f4995e0c6c016a44e8ffb8dd | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.59e-05 | 190 | 51 | 4 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.73e-05 | 191 | 51 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 7.01e-05 | 193 | 51 | 4 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | proximal-Epithelial-Serous|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.29e-05 | 195 | 51 | 4 | cb62f04f0e45bfb36eed2e7a3fc54d6d390b2ed1 | |
| ToppCell | proximal-Epithelial-Serous-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.29e-05 | 195 | 51 | 4 | 06b73abc1f32543f2a51db52dc6424a2a398fe0f | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 7.29e-05 | 195 | 51 | 4 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | proximal-3-Epithelial-Serous|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.29e-05 | 195 | 51 | 4 | 24a6a566143b04e37ad002e4c55037a0460ac2ef | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.44e-05 | 196 | 51 | 4 | ce13af36fc2932e8125013041742593ff3d07e86 | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.44e-05 | 196 | 51 | 4 | 96e5c6d155273e82ebafa180df8bb589c3e3e54e | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.89e-05 | 199 | 51 | 4 | ef1a0c278c23614fd6a3218a9733abe6ecd6f686 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.04e-05 | 200 | 51 | 4 | ad52b38df5c71f28829b04cd0e6b97f0f9f7610a | |
| Drug | pentylenetetrazol | 9.69e-06 | 130 | 50 | 5 | CID000005917 | |
| Drug | auto inducer 2 | 1.71e-05 | 23 | 50 | 3 | CID000448719 | |
| Drug | gabapentin | 3.43e-05 | 169 | 50 | 5 | CID000003446 | |
| Drug | AC1L1B1W | 3.49e-05 | 84 | 50 | 4 | CID000001248 | |
| Drug | propofol | 6.15e-05 | 191 | 50 | 5 | CID000004943 | |
| Drug | flurazepam | 6.21e-05 | 35 | 50 | 3 | CID000003393 | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 6.95e-05 | 196 | 50 | 5 | 1679_DN | |
| Drug | Panthenol (D) [81-13-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 7.12e-05 | 197 | 50 | 5 | 1680_DN | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 7.29e-05 | 198 | 50 | 5 | 3575_UP | |
| Drug | Aztreonam [78110-38-0]; Up 200; 9.2uM; HL60; HG-U133A | 7.29e-05 | 198 | 50 | 5 | 1435_UP | |
| Drug | sipatrigine | 7.35e-05 | 37 | 50 | 3 | CID000060803 | |
| Drug | secobarbital | 7.35e-05 | 37 | 50 | 3 | CID000005193 | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 7.47e-05 | 199 | 50 | 5 | 5540_UP | |
| Drug | DMCM | 7.96e-05 | 38 | 50 | 3 | CID000104999 | |
| Drug | zaleplon | 8.61e-05 | 39 | 50 | 3 | CID000005719 | |
| Drug | Quazepam | 9.86e-05 | 7 | 50 | 2 | DB01589 | |
| Drug | gaboxadol | 1.00e-04 | 41 | 50 | 3 | CID000003448 | |
| Drug | fentanyl | 1.04e-04 | 111 | 50 | 4 | CID000003345 | |
| Drug | zolpidem | 1.16e-04 | 43 | 50 | 3 | CID000005732 | |
| Drug | hydroxybutyrate | 1.19e-04 | 115 | 50 | 4 | CID000010413 | |
| Drug | pentobarbital | 1.30e-04 | 224 | 50 | 5 | CID000004737 | |
| Drug | Adinazolam | 1.31e-04 | 8 | 50 | 2 | DB00546 | |
| Drug | Fludiazepam | 1.31e-04 | 8 | 50 | 2 | DB01567 | |
| Drug | Clotiazepam | 1.31e-04 | 8 | 50 | 2 | DB01559 | |
| Drug | Cinolazepam | 1.31e-04 | 8 | 50 | 2 | DB01594 | |
| Drug | Prazepam | 1.31e-04 | 8 | 50 | 2 | DB01588 | |
| Drug | Estazolam | 1.31e-04 | 8 | 50 | 2 | DB01215 | |
| Drug | Halazepam | 1.31e-04 | 8 | 50 | 2 | DB00801 | |
| Drug | 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane | 1.31e-04 | 8 | 50 | 2 | ctd:C091518 | |
| Drug | thymol | 1.42e-04 | 46 | 50 | 3 | CID000006989 | |
| Drug | taurine | 1.50e-04 | 231 | 50 | 5 | CID000001123 | |
| Drug | Ethchlorvynol | 1.68e-04 | 9 | 50 | 2 | DB00189 | |
| Drug | Diazepam | 1.68e-04 | 9 | 50 | 2 | DB00829 | |
| Drug | vigabatrin | 1.71e-04 | 49 | 50 | 3 | CID000005665 | |
| Drug | muscimol | 1.85e-04 | 129 | 50 | 4 | CID000004266 | |
| Drug | sodium | SLC6A1 GABRB3 SLC25A3 TRPM7 SLC6A16 ASIC5 SLC7A6 SLC13A2 GABRA3 | 1.89e-04 | 944 | 50 | 9 | CID000000923 |
| Drug | Chlordiazepoxide | 2.10e-04 | 10 | 50 | 2 | DB00475 | |
| Drug | Clobazam | 2.10e-04 | 10 | 50 | 2 | DB00349 | |
| Drug | Bromazepam | 2.10e-04 | 10 | 50 | 2 | DB01558 | |
| Drug | Clonazepam | 2.10e-04 | 10 | 50 | 2 | DB01068 | |
| Drug | Oxazepam | 2.10e-04 | 10 | 50 | 2 | DB00842 | |
| Drug | Midazolam | 2.10e-04 | 10 | 50 | 2 | DB00683 | |
| Drug | Flurazepam | 2.10e-04 | 10 | 50 | 2 | DB00690 | |
| Drug | Alprazolam | 2.57e-04 | 11 | 50 | 2 | DB00404 | |
| Drug | Temazepam | 2.57e-04 | 11 | 50 | 2 | DB00231 | |
| Drug | Nitrazepam | 2.57e-04 | 11 | 50 | 2 | DB01595 | |
| Drug | Lorazepam | 2.57e-04 | 11 | 50 | 2 | DB00186 | |
| Drug | AC1L2F0S | 2.57e-04 | 11 | 50 | 2 | CID000070859 | |
| Drug | Triazolam | 2.57e-04 | 11 | 50 | 2 | DB00897 | |
| Drug | oxiracetam | 2.57e-04 | 11 | 50 | 2 | CID000004626 | |
| Drug | Clorazepate | 2.57e-04 | 11 | 50 | 2 | DB00628 | |
| Drug | benzodiazepine | 2.67e-04 | 142 | 50 | 4 | CID000134664 | |
| Drug | ketamine | 2.70e-04 | 262 | 50 | 5 | CID000003821 | |
| Drug | flunitrazepam | 2.97e-04 | 59 | 50 | 3 | CID000003380 | |
| Drug | AC1Q5UBL | 2.97e-04 | 146 | 50 | 4 | CID000005466 | |
| Drug | TAK-220 | 3.08e-04 | 12 | 50 | 2 | CID005275766 | |
| Drug | pyrrolidine-2,4-dicarboxylate | 3.28e-04 | 61 | 50 | 3 | CID000003868 | |
| Drug | tetradotoxin | 3.36e-04 | 428 | 50 | 6 | CID000020382 | |
| Drug | gamma-Aminobutyric Acid | 3.44e-04 | 62 | 50 | 3 | ctd:D005680 | |
| Drug | benzo(k)fluoranthene | 3.52e-04 | 610 | 50 | 7 | ctd:C022921 | |
| Drug | isoflurane | 3.60e-04 | 279 | 50 | 5 | CID000003763 | |
| Drug | AC1NRNSN | 3.61e-04 | 63 | 50 | 3 | CID005244174 | |
| Disease | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) measurement | 8.88e-05 | 9 | 47 | 2 | EFO_0800409 | |
| Disease | 1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) measurement | 8.88e-05 | 9 | 47 | 2 | EFO_0800403 | |
| Disease | 1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) measurement | 8.88e-05 | 9 | 47 | 2 | EFO_0800272 | |
| Disease | 1-stearoyl-2-linoleoyl-GPE (18:0/18:2) measurement | 1.11e-04 | 10 | 47 | 2 | EFO_0800402 | |
| Disease | cholesteryl ester 22:5 measurement | 1.11e-04 | 10 | 47 | 2 | EFO_0021444 | |
| Disease | phosphatidylcholine 32:0 measurement | 1.35e-04 | 11 | 47 | 2 | EFO_0010372 | |
| Disease | level of Phosphatidylcholine (16:0_16:0) in blood serum | 2.57e-04 | 15 | 47 | 2 | OBA_2045067 | |
| Disease | sciatic neuropathy (implicated_via_orthology) | 6.15e-04 | 23 | 47 | 2 | DOID:11446 (implicated_via_orthology) | |
| Disease | gamma-linolenic acid measurement | 6.70e-04 | 24 | 47 | 2 | EFO_0007762 | |
| Disease | Amyotrophic Lateral Sclerosis, Guam Form | 1.12e-03 | 31 | 47 | 2 | C0543859 | |
| Disease | cholesteryl ester 22:6 measurement | 1.19e-03 | 32 | 47 | 2 | EFO_0010350 | |
| Disease | lysophosphatidylethanolamine 18:1 measurement | 1.35e-03 | 34 | 47 | 2 | EFO_0010368 | |
| Disease | cholesteryl ester 18:3 measurement | 1.86e-03 | 40 | 47 | 2 | EFO_0010346 | |
| Disease | metabolite measurement | 1.92e-03 | 560 | 47 | 5 | EFO_0004725 | |
| Disease | susceptibility to infectious disease measurement | 2.05e-03 | 42 | 47 | 2 | EFO_0008422 | |
| Disease | cholesteryl ester 20:4 measurement | 2.25e-03 | 44 | 47 | 2 | EFO_0010348 | |
| Disease | Gastric Adenocarcinoma | 2.35e-03 | 45 | 47 | 2 | C0278701 | |
| Disease | lung adenocarcinoma | 2.70e-03 | 174 | 47 | 3 | EFO_0000571 | |
| Disease | glycerophospholipid measurement | 2.78e-03 | 49 | 47 | 2 | EFO_0007630 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.78e-03 | 49 | 47 | 2 | DOID:0060037 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SFIYFLIAWYVRNVF | 1261 | Q86UK0 | |
| LYVWNNYFVVRYSLE | 381 | O94910 | |
| VYDQWFITLFNIVYT | 901 | Q8TF62 | |
| FISQIIYYFREYSWS | 286 | Q6UXS9 | |
| GQSWSLILLIYFFFY | 106 | Q9UN42 | |
| YFFYKNVAYVNLLFW | 1116 | Q9P241 | |
| AWLIFYFIQKIRYTN | 211 | Q86XS8 | |
| LVWVPFIYSFQAFYL | 461 | Q14739 | |
| YNFISIFSFLEIWYT | 76 | Q8NGY3 | |
| KQVYNFIYDVSFWSF | 396 | Q15058 | |
| TALQWFIYDSVKVYF | 326 | Q00325 | |
| NVWTYYVSYAVFFIS | 196 | Q7Z429 | |
| WIYNFIIQVTSFLFY | 211 | Q9GZQ4 | |
| AYWIVVNFREAYNLF | 186 | O60547 | |
| ISLFYIFNFLKYTLW | 306 | Q9BUM1 | |
| WELQIFFFVTFSLIY | 21 | Q8NH43 | |
| LFAIFNLVYWATYVN | 466 | P34903 | |
| FPFTFSLFNLVYWLY | 456 | P28472 | |
| QDITWVSSFYIYFIT | 336 | A8MWK0 | |
| YFVNSFLIATVYWFN | 281 | Q9UJ42 | |
| NVNLTIFTARLYYFW | 296 | Q8IUX4 | |
| QQQWLELFSVYFRLY | 161 | Q13315 | |
| FSFPFQTYYLLDQWV | 86 | P51685 | |
| IWQILYAFFSYAEVL | 306 | Q7Z3C6 | |
| IYQAFYSEVFSLWKQ | 636 | Q5TEA3 | |
| YLFTNFYWICIFFLL | 466 | Q9NY37 | |
| NITFYVYVSNFSWPI | 1201 | Q5VV63 | |
| PLYFQWYIFYFVIQR | 276 | O60427 | |
| EFFYNWYFLITASTL | 191 | Q9Y5N1 | |
| QALWAYRSYLIVFFV | 6 | Q13183 | |
| IISLAWLVFYYIQRF | 221 | Q9ULK6 | |
| VFYALLFVFIYVQLW | 51 | O60478 | |
| YFLKIANFSNYIFLW | 106 | Q9NYW0 | |
| LLFFWVNYPVYQEFL | 146 | P59536 | |
| QVIQFSLRDYVQYWY | 106 | Q9Y5W8 | |
| LGLYFNVVNSWIIFY | 196 | Q9GZN6 | |
| YQIYFWNIATIAVFY | 446 | Q8NBJ9 | |
| IVIISWAIYYLYNSF | 141 | P30531 | |
| RTVQYYLVGWQFLIY | 171 | Q9H841 | |
| VYSLFFANNNWYFFL | 771 | O75182 | |
| KTFYWDFYTNRTVQI | 96 | P12273 | |
| IKFLLSVVQSYFVYW | 141 | A0A1B0GV85 | |
| WENQFYYLFGFLFLV | 526 | Q92544 | |
| FYIFTWSFLLSQLAY | 301 | O15374 | |
| ITLFPFISWVYIYIN | 131 | Q6QAJ8 | |
| AIFALQFTYYLWVKS | 226 | Q8TCJ2 | |
| VFWVFFSAYIFNSNV | 201 | Q8TCT6 | |
| IYYNNIIAITIFFAW | 366 | Q9NZM6 | |
| VFQLINYFSFSYWFF | 386 | Q92536 | |
| FVVSFYYGTITWYNI | 176 | Q96HH4 | |
| WLTPFLQAVYLFVQY | 1071 | Q96QT4 | |
| YRVTVATILYFSWFN | 261 | Q9H6D3 |